Krebs Biochemicals & Industries Limited
NSE:KREBSBIO.NS
Overview | Financials
Company Name | Krebs Biochemicals & Industries Limited |
Symbol | KREBSBIO.NS |
Currency | INR |
Price | 92.51 |
Market Cap | 1,994,571,106 |
Dividend Yield | 0% |
52-week-range | 60.35 - 121.55 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jitendra Rameshchandra Shah |
Website | https://krebsbiochem.com |
An error occurred while fetching data.
About Krebs Biochemicals & Industries Limited
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD